Table 3.
Clinicopathologic factors affecting progression-free and overall survivals in 29 patients who showed underweight after treatment.
| Characteristics | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | Adjusted HR | 95% CI | P value | |
| Progression-free survival | ||||||
| ≥53 years | 1.91 | 0.79–4.63 | 0.15 | — | — | — |
| Stage IV disease | 1.88 | 0.68–5.18 | 0.23 | 4.89 | 1.14–20.94 | 0.03 |
| Grade 3 disease | 0.94 | 0.33–2.70 | 0.91 | — | — | — |
| Nonserous histology | 2.99 | 1.13–7.90 | 0.03 | — | — | — |
| No neoadjuvant chemotherapy | 1.54 | 0.51–4.64 | 0.45 | — | — | — |
| ≤6 cycles of adjuvant chemotherapy | 1.10 | 0.40–3.01 | 0.86 | — | — | — |
| Suboptimal debulking surgery | 3.89 | 1.55–9.74 | <0.01 | 10.04 | 1.48–68.13 | 0.02 |
| Weight loss ≥10% | 4.07 | 1.55–10.64 | <0.01 | 6.90 | 1.51–31.54 | 0.01 |
| Overall survival | ||||||
| ≥53 years | 2.07 | 0.62–6.92 | 0.24 | — | — | — |
| Stage IV disease | 1.92 | 0.40–9.25 | 0.42 | 11.9 | 1.00–141.1 | 0.05 |
| Grade 3 disease | 0.77 | 0.17–3.47 | 0.73 | — | — | — |
| Nonserous histology | 2.58 | 0.73–9.15 | 0.14 | — | — | — |
| No neoadjuvant chemotherapy | 1.27 | 0.27–6.02 | 0.77 | — | — | — |
| ≤6 cycles of adjuvant chemotherapy | 3.84 | 0.78–18.91 | 0.10 | — | — | — |
| Suboptimal debulking surgery | 2.64 | 0.88–7.91 | 0.08 | — | — | — |
| Weight loss ≥10% | 12.81 | 2.54–64.65 | <0.01 | 15.27 | 1.42–164.5 | 0.02 |